+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bristol-Myers Squibb - logo

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

From
From
From
From
CRF1 Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

CRF1 Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Postherpetic Neuralgia - Pipeline Insight, 2025 - Product Thumbnail Image

Postherpetic Neuralgia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 65 Pages
  • Global
From
Orphan Drugs Market Report 2025 - Product Thumbnail Image

Orphan Drugs Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Small Molecule Drug Discovery Market Report 2025 - Product Thumbnail Image

Small Molecule Drug Discovery Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Drug Formulation Market Report 2025 - Product Thumbnail Image

Drug Formulation Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
RNA Targeting Small Molecule Drug Discovery Market Report 2025 - Product Thumbnail Image

RNA Targeting Small Molecule Drug Discovery Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
HDAC Inhibitors Market 2023-2027 - Product Thumbnail Image

HDAC Inhibitors Market 2023-2027

  • Report
  • January 2023
  • 157 Pages
  • Global
From
Loading Indicator